Vereos Digital PET/CT

Proven accuracy inspires confidence

Find similar products

Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution . With proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain, Vereos exemplifies an established total solution to reveal more, earlier, to help you improve patient care and manage costs.

Features
Improved lesion detectability

Improved lesion detectability

While visualization of small lesions is essential for clinicians to diagnose, stage and monitor therapy in oncology patients, in molecular imaging, the challenge is being able to detect these small lesions reliably [1]. Vereos provides improved detectability & characterization of small lesions [2]
Low PET dose

Low PET dose

Dose reduction in PET radiopharmaceutical administration does not have to be a trade-off between radiation exposure and diagnostic image quality. Utilizing appropriate reconstruction algorithms, reduced dose can be administered with no reduction in diagnostic confidence. Vereos provides uncompromised image quality & detectability at 1/2 the PET dose [3]
Fast scans

Fast scans

Fast scanning allows patients to spend less time in the scanner, enhancing the overall patient experience. Vereos provides uncompromised lesion detectability at 1/10 the time [4]
Ready for the future

Ready for the future

With the highest count rate in the industry , Vereos provides enhanced diagnostic confidence with emerging applications that use short half-life tracers.

Experiences with the world’s first and only digital PET/CT  

 

 

 

Hear from early adopters of the Vereos digital PET/CT at The Ohio State University Wexner Medical Center about what it means to have a true partner in innovation.

dr-kikut
Watch video

Dr. Jay Kikut, University of Vermont Medical Center, discusses how Vereos Digital PET/CT comes ready for implementation.

 

“This system provides tools that you can be ready in a week or so. The system was being tested and validated by Philips for over 3 years. It’s a big change. So it really comes ready.”

dr-carrio
Watch video

Dr. Ignasi Carrió, Hospital Sant Pau in Barcelona, shares the difference between Vereos digital PET/CT over analog PET.

 

“The major difference with prior technologies, so say the analog PET/CT, is that we are able to detect smaller lesions earlier.”

DrKnopp_Revised
Watch video

Dr. Michael Knopp, MD, PhD, discusses partnering with Philips and how the Vereos digital PET/CT is a major leap in the advancement of PET imaging.

 

 " I look for a partner that is committed to the innovation we need."

Dr. Jun Zhang, PhD, DABR, shares why he personally believes that the Vereos digital PET/CT system is a game-changer in the field of Nuclear Medicine.

 

"I personally believe (this system) is going to change the world in the field of nuclear medicine."

Katherine Binzel, PhD, shares her overall enthusiasm for the Vereos digital PET/CT and ease of the workflow.

 

 

"...it is the future of medicine."

imv-2018award

2017-18 ServiceTrak™ Award

 

Philips has been recognized by IMV as the 2017-2018 category winner for Best Service in PET Imaging. IMV, part of the Science and Medicine Group, is the leading market research provider to the imaging industry and surveys from a randomized database of US hospitals and imaging centers. This award acknowledges the combined performance of an exceptional Philips service delivery team and service innovation by design within Philips PET CT products. With customizable maintenance and performance services, Philips works as a trusted service provider to help our customers get the most from their PET CT imaging systems and to meet the challenges of today’s demanding healthcare environment. Together, we can create a healthier future.

  • [1] Hussain T, Nguyen QT. Molecular Imaging for Cancer Diagnosis and Surgery. Advanced drug delivery reviews. 2014;66:90-100. doi:10.1016/j.addr.2013.09.007.
  • [2] Nguyen NC,  Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET, J Nucl Med 2015; 56:1378–1385
  • [3] Knopp,M, Binzel,K, Bardos,P, Knopp,M, Wright,C, Zhang,J, Nagar,V, Hall,N, Maniawski,P, Next Generation Digital PET/CT: A Phase I Intra-Individual Comparison with Current Photomultiplier TOF PET/CT. Radiological Society of North America 2015 Scientific Assembly and Annual Meeting, November 29 - December 4, 2015, Chicago IL.
  • [4] Zhang J., Evaluation of speed of PET acquisition: How fast can we go? - A validation of list mode PET simulation approach with true acquisitions, SNMMI 2017